Wockhardt aims to turnaround business operations

27 Jul 2023 Evaluate

Wockhardt is aiming to turnaround its business operations and has perused important strategic initiatives for the same. The company is eying big on the restructuring of the US Business, vaccine tie-up with Serum for vaccine manufacturing in UK and Novel Antibiotics research to drive the business forward. 

In the restructuring of its US operations, company is shutting down its manufacturing facility at Morton Grove and transferring the site to contract manufacturing organisations. This restructuring is estimated to result in annual savings of around $12 million. Post restructuring company looks to maintain sales with a 40 percent gross margin and manufacture few products with higher margin through a third party.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.


Wockhardt Share Price

1230.95 58.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.